Us Bancorp \De\ Summit Therapeutics Inc. Transaction History

Us Bancorp \De\

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 11, 2022	SELL	$2.45 - $5.64 $830 - $1,911	-339 Closed	0 $0
Q3 2021 Nov 10, 2021	SELL	$4.83 - $8.27 $4,284 - $7,335	-887 Reduced 72.35%	339 $2,000
Q2 2021 Aug 05, 2021	SELL	$5.15 - $8.46 $2,945 - $4,839	-572 Reduced 31.81%	1,226 $9,000
Q1 2021 Apr 28, 2021	BUY	$5.17 - $11.19 $8,178 - $17,702	1,582 Added 732.41%	1,798 $10,000
Q4 2020 Feb 04, 2021	BUY	$3.25 - $6.0 $702 - $1,296	216 New	216 $1,000

201

76.4M

2.01M

2.83M

Ticker SMMT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 201,215,008
Market Cap $4.42B
Description
Summit Therapeutics Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines to treat infectious diseases in the United States and Latin America. It conducts clinical programs focusing on Clostridioides difficile infection (CDI). The company's lead product candidate is ridinilazole, an orally administered small molecu...

Get notified when there are updates to the investment portfolio of Us Bancorp \De\, based on Form 13F filings with the SEC.

Stay updated on Us Bancorp \De\ with notifications on news.